The New England Journal of Medicine is commonly regarded as one of
the most esteemed journals in medicine and influences the practice of medicine
around the world. But about two-thirds of its articles on new drugs are
sponsored by pharmaceutical companies and most of those are co-written by their
employees. The journal’s editors have put in place numerous safeguards to
prevent bias. In some recent high-profile cases, some of those articles have
either overstated the benefits or underestimated the risks of a sponsor’s drugs. (Ver)
Entradas
No hay comentarios:
Publicar un comentario